Cargando…

Analysis of molecular resistance to azole and echinocandin in Candida species in patients with vulvovaginal candidiasis

BACKGROUND AND PURPOSE: Vulvovaginal candidiasis (VVC) is considered the most common mucosal infection caused by Candida species. Azoles were considered the first-line treatment for VVC or recurrent vulvovaginal candidiasis (RVVC) in both healthy and immunocompromised populations. Recently, azole-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lotfali, Ensieh, Erami, Mahzad, Fattahi, Mahsa, Nemati, Houshang, Ghasemi, Zeinab, Mahdavi, Elham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Society of Medical Mycology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825790/ https://www.ncbi.nlm.nih.gov/pubmed/36654793 http://dx.doi.org/10.18502/cmm.8.2.10326

Ejemplares similares

Does alternation of Candida albicans TUP1 gene expression affect the progress of symptomatic recurrent vulvovaginal candidiasis?
por: Ghazanfari, Mona, et al.
Publicado: (2020)

Isolation of Candida africana in oral candidiasis: First report among cancer patients in Iran
por: Lotfali, Ensieh, et al.
Publicado: (2020)

Isolation of Different Species of Candida in Patients With Vulvovaginal Candidiasis From Sari, Iran
por: Hedayati, Mohammad Taghi, et al.
Publicado: (2015)

Identification of Candida Species Associated with Vulvovaginal Candidiasis by Multiplex PCR
por: Mahmoudi Rad, Mahnaz, et al.
Publicado: (2012)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

Biofilm Formation and Aspartyl Proteinase Activity and Their Association with Azole Resistance Among Candida albicans Causing Vulvovaginal Candidiasis, Egypt
por: Gerges, Marian A, et al.
Publicado: (2023)

Low prevalence of antifungal resistant Candida africana, in the C. albicans complex causing vulvovaginal candidiasis
por: Farahyar, Shirin, et al.
Publicado: (2020)

In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis
por: Boikov, Dina A., et al.
Publicado: (2017)

Oral Candida colonization and anti-fungal susceptibility pattern in patients with hematological malignancy
por: Talebshoushtari Zadeh, Maryam, et al.
Publicado: (2022)

Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis
por: Rodríguez-Cerdeira, Carmen, et al.
Publicado: (2020)

Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution
por: David, Helma, et al.
Publicado: (2023)

Emergence of azole-resistant Candida species in AIDS patients with oropharyngeal candidiasis in Iran
por: Katiraee, F, et al.
Publicado: (2015)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022)

Candidiasis by Candida glabrata, Candida nivariensis and Candida bracarensis in Galleria mellonella: Virulence and Therapeutic Responses to Echinocandins
por: Hernando-Ortiz, Ainara, et al.
Publicado: (2021)

Candida albicans and Candida dubliniensis Show Different Trailing Effect Patterns When Exposed to Echinocandins and Azoles
por: Ayadi, Rania, et al.
Publicado: (2020)

Molecular Identification and Antifungal Susceptibility Pattern of Non-albicans Candida Species Isolated from Vulvovaginal Candidiasis
por: Nejat, Ziba Abbasi, et al.
Publicado: (2018)

Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae
por: Hashemi, Seyed Ebrahim, et al.
Publicado: (2019)

A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women
por: Arastehfar, Amir, et al.
Publicado: (2021)

First report of Vulvovaginitis due to Cryptococcus magnus in Iran
por: Ghajari, Ali, et al.
Publicado: (2018)

Multilocus sequence typing analysis of Candida africana from vulvovaginal candidiasis
por: Zhu, Y. X., et al.
Publicado: (2019)

Recurrent Vulvovaginal Candidiasis: Could It Be Related to Cell-Mediated Immunity Defect in Response to Candida Antigen?
por: Talaei, Zahra, et al.
Publicado: (2017)

Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles
por: Aslani, Narges, et al.
Publicado: (2021)

Candidiasis vulvovaginal: revisión bibliográfica.
por: Caballero Salmeron, María Esther
Publicado: (1995)

New Treatments for Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1996)

Changing Trends of Vulvovaginal Candidiasis
por: Vijaya, Doddaiah, et al.
Publicado: (2014)

Clinicomycological study of vulvovaginal candidiasis
por: Seeniammal, S., et al.
Publicado: (2021)

Recurrent Vulvovaginal Candidiasis: a Dynamic Interkingdom Biofilm Disease of Candida and Lactobacillus
por: McKloud, Emily, et al.
Publicado: (2021)

Susceptibility Pattern of Caspofungin-Coated Gold Nanoparticles Against Clinically Important Candida Species
por: Salehi, Zahra, et al.
Publicado: (2021)

Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis
por: Zhang, Ming-rui, et al.
Publicado: (2020)

2116. Comparative Effectiveness of Amphotericin B, Azoles, and Echinocandins in the Treatment of Candidemia and Invasive Candidiasis: A Systematic Review and Network Meta-Analysis
por: Demir, Koray K, et al.
Publicado: (2019)

In Vitro Antifungal Susceptibility Profile of Miltefosine against a Collection of Azole and Echinocandins Resistant Fusarium Strains
por: Nosratabadi, Mohsen, et al.
Publicado: (2022)

Virulence Factors of Candida spp. and Host Immune Response Important in the Pathogenesis of Vulvovaginal Candidiasis
por: Czechowicz, Paulina, et al.
Publicado: (2022)

An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis
por: Rosati, Diletta, et al.
Publicado: (2020)

Divergent EGFR/MAPK-Mediated Immune Responses to Clinical Candida Pathogens in Vulvovaginal Candidiasis
por: Zhang, Jingyun, et al.
Publicado: (2022)

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis
por: Miao, Jian, et al.
Publicado: (2023)

Azole potentiation in Candida species
por: Stenkiewicz-Witeska, Jan S., et al.
Publicado: (2023)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
por: Rosati, Diletta, et al.
Publicado: (2020)

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022)

Clinical and morphopathological assay in vulvovaginal candidiasis
por: Manolea, Maria Magdalena, et al.
Publicado: (2022)

Insights and advances in recurrent vulvovaginal candidiasis
por: San Juan Galán, Javier, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v2bcbaorhct0bsaa1jtdet9l4v